A surviving patient after a cumulative dose of 250 g of cyclophosphamide.
a Internal Medicine, Department of Rheumatology , Antakya Hospital , Hatay.
R
R
Mercan
b Department of Internal Medicine, Division of Rheumatology , Gazi University Hospital , Ankara , Turkey.
B
B
Bitik
c Department of Pathology , Gazi University Hospital , Ankara , Turkey.
Ö
Ö
Ekinci
b Department of Internal Medicine, Division of Rheumatology , Gazi University Hospital , Ankara , Turkey.
B
B
Goker
D000284:Administration, Oral; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008875:Middle Aged; D015423:Scleritis / Q000139:chemically induced* / Q000175:diagnosis; D028761:Withholding Treatment
D003520:Cyclophosphamide